Notably, Klichinsky et al. described an anti-HER2 CAR-macrophage (CAR-M, CT-0508), endowed with antigen-specific phagocytic activity, significantly reduced metastatic tumor burden in humanized mouse cancer model [138]. Here, ERBB2 is linked to cancer.